Pre‐transplant soluble CD30 in combination with total DSA but not pre‐transplant C1q‐DSA predicts antibody‐mediated graft loss in presensitized high‐risk kidney transplant recipients

Publisher： John Wiley & Sons Inc

E-ISSN： 2059-2310|87|2|89-99

ISSN： 2059-2302

Source： HLA, Vol.87, Iss.2, 2016-02, pp. : 89-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pre‐transplant antibody screening and anti‐CD154 costimulation blockade promote long‐term xenograft survival in a pig‐to‐primate kidney transplant model

By  

XENOTRANSPLANTATION (ELECTRONIC), Vol. 22, Iss. 3, 2015-05 ,pp. : 221-230

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pretransplant virtual PRA and long‐term outcomes of kidney transplant recipients

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 6, 2015-06 ,pp. : 710-719

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pre‐transplant angiotensin receptor II type 1 antibodies and risk of post‐transplant focal segmental glomerulosclerosis recurrence

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 7, 2015-07 ,pp. : 606-611

John Wiley & Sons Inc

Access to resources Recommend Favorite

The impact of C4d‐negative acute antibody‐mediated rejection on short‐term prognosis among kidney transplant recipients

By  

NEPHROLOGY, Vol. 20, Iss. S2, 2015-07 ,pp. : 16-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors for cytomegalovirus reactivation after liver transplantation: Can pre‐transplant cytomegalovirus antibody titers predict outcome?

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 4, 2015-04 ,pp. : 539-546

John Wiley & Sons Inc

Access to resources Recommend Favorite